What causes asymmetric Intrauterine Growth Restriction (IUGR) in a pregnant individual?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Asymmetric Intrauterine Growth Restriction: Causes

Asymmetric IUGR is primarily caused by placental insufficiency due to suboptimal uteroplacental perfusion, which accounts for 25-30% of all fetal growth restriction cases and is the predominant etiology in late-onset (third trimester) presentations. 1, 2

Primary Etiology: Placental Insufficiency

Placental insufficiency represents the leading cause of asymmetric IUGR, particularly in late-onset cases (≥32 weeks gestation). 1, 2 This pathophysiology results in:

  • Preferential blood flow redistribution to protect the fetal brain at the expense of abdominal and somatic growth, creating the characteristic "head-sparing" pattern seen in asymmetric IUGR 1
  • Poor placental function and hypoxemia that manifests as impaired fetal growth 3

Maternal Vascular and Hypertensive Disorders

Maternal hypertensive disorders are a key association with late-onset asymmetric FGR, as these conditions directly compromise uteroplacental perfusion. 1 Specific maternal factors include:

  • Chronic maternal diseases affecting placental perfusion 2
  • Pre-eclampsia-related placental changes 4
  • Maternal vascular disease 1

Timing-Dependent Etiologic Patterns

The etiology of asymmetric IUGR varies significantly by gestational age at presentation:

Late-Onset (Third Trimester)

  • Placental insufficiency predominates, especially related to hypertension and maternal vascular disease 1
  • Asymmetric FGR with head-sparing is characteristically more common in these late-onset cases 1

Early-Onset (Before 32 weeks)

  • Chromosomal anomalies, syndromes, and viral infections are more common etiologies 1
  • Chromosomal disorders and congenital malformations account for approximately 20% of FGR cases overall 1, 2

Pathophysiologic Classification

The distinction between asymmetric and symmetric IUGR reflects different underlying mechanisms:

  • Asymmetric IUGR (nutritional IUGR): Results from placental insufficiency occurring later in pregnancy, leading to redistribution of blood flow that spares the brain while compromising abdominal/liver growth 4
  • Symmetric IUGR (reduced growth potential): Typically results from early insults affecting overall growth potential 4

Additional Contributing Factors

Beyond placental insufficiency, other etiologies that may present with or contribute to asymmetric patterns include:

  • Fetal factors: Genetic diseases, congenital malformations, infections, multiple gestations, and placental/cord abnormalities 5
  • Maternal factors: Decreased uteroplacental blood flow, reduced blood volume, decreased oxygen carrying capacity, poor nutrition status, teratogens, and socioeconomic factors 5

Critical Clinical Pitfall

Approximately 10-20% of fetuses with FGR have congenital anomalies or chromosomal disorders, making detailed fetal structural survey essential even when placental insufficiency appears to be the primary cause. 2, 6 This is particularly important in early-onset cases where chromosomal abnormalities are more prevalent. 1

References

Guideline

Asymmetric Intrauterine Growth Restriction Causes and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fetal Growth Restriction Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pathological assessment of intrauterine growth restriction.

Best practice & research. Clinical obstetrics & gynaecology, 2009

Research

Non-placental causes of intrauterine growth restriction.

Seminars in perinatology, 2008

Guideline

Fetal Growth Restriction Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.